Clinical Trial Update: Combined Chemotherapy With or Without Zoledronic Acid for Patients With Osteosarcoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating chemotherapy with or without zoledronic acid for osteosarcoma; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: UNICANCER | Conditions: Sarcoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING